These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 947966)

  • 1. Relationship of sulfamethazine disposition kinetics to acetylator phenotype in man. A preliminary study.
    Chapron CJ; Blum MR
    J Clin Pharmacol; 1976 Jul; 16(7):338-44. PubMed ID: 947966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic discrimination of three sulfamethazine acetylation phenotypes.
    Chapron DJ; Kramer PA; Mercik SA
    Clin Pharmacol Ther; 1980 Jan; 27(1):104-13. PubMed ID: 7351110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of nonlinear disposition kinetics of sulfamethazine.
    du Souich P; Lalka D; Slaughter R; Elvin AT; McLean AJ
    Clin Pharmacol Ther; 1979 Feb; 25(2):172-83. PubMed ID: 759070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-dependent changes in sulfamethazine kinetics in rapid and slow isoniazid acetylators.
    Olson W; Miceli J; Weber W
    Clin Pharmacol Ther; 1978 Feb; 23(2):204-11. PubMed ID: 620482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between the metabolism of procainamide and sulfamethazine.
    Giardina E-GV ; Stein RM; Bigger JT
    Circulation; 1977 Feb; 55(2):388-94. PubMed ID: 832354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetylation of sulfamethazine in a Nigerian population.
    Eze LC; Obidoa O
    Biochem Genet; 1978 Dec; 16(11-12):1073-7. PubMed ID: 751642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening methods using sulfamethazine for determining acetylator phenotype.
    du Souich P; McLean AJ; Stoeckel K; Ohlendorf D; Gibaldi M
    Clin Pharmacol Ther; 1979 Dec; 26(6):757-65. PubMed ID: 498718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulfadimidine and isoniazid loading in man and laboratory rats. Pharmacokinetic and pharmacogenetic results on drug acetylation.
    Dubbels R; Kattner E; Sell-Maurer D; Schloot W
    Arzneimittelforschung; 1980; 30(9):1574-9. PubMed ID: 7193028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-acetylation and oxidative capacity in aged volunteers determined with sulfamethazine and antipyrine.
    Siegmund W; Franke G; Wulkow R; Hanke W; Thonack R
    Int J Clin Pharmacol Ther Toxicol; 1991 Dec; 29(12):469-73. PubMed ID: 1813431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A simple pharmacokinetic method for separating the three acetylation phenotypes: a preliminary report.
    Lee EJ; Lee LK
    Br J Clin Pharmacol; 1982 Mar; 13(3):375-8. PubMed ID: 7059437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphic acetylation of the antibacterials, sulfamethazine and dapsone, in South Indian subjects.
    Peters JH; Gordon GR; Karat AB
    Am J Trop Med Hyg; 1975 Jul; 24(4):641-8. PubMed ID: 1155699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential influence of body weight on the clearance of polymorphically acetylated drugs.
    Chapron DJ; Kramer PA; Mercik SA
    J Clin Pharmacol; 1982; 22(5-6):271-5. PubMed ID: 7107974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inheritance of acetylator phenotype in mice.
    Tannen RH; Weber WW
    J Pharmacol Exp Ther; 1980 Jun; 213(3):480-4. PubMed ID: 6970808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics, metabolism, and renal excretion of sulfadimidine and its N4-acetyl and hydroxy metabolites in humans.
    Vree TB; Hekster YA; Nouws JF; Baakman M
    Ther Drug Monit; 1986; 8(4):434-9. PubMed ID: 3824429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetylation phenotype in hypertensive patients.
    Huang CY; Chu JY; Yen TC
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1992 Jan; 8(1):1-5. PubMed ID: 1548734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disposition of sulfonamides in food-producing animals IV: Pharmacokinetics of sulfamethazine in cattle following administration of an intravenous dose and three oral dosage forms.
    Bevill RF; Dittert LW; Bourne DW
    J Pharm Sci; 1977 May; 66(5):619-23. PubMed ID: 874742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetylator phenotype determination in the rabbit: sulphamethazine or sulphadiazine, the choice of a substrate.
    du Souich P; Courteau H
    J Pharm Pharmacol; 1981 Apr; 33(4):261-3. PubMed ID: 6115918
    [No Abstract]   [Full Text] [Related]  

  • 18. Age and dosage dependency in the plasma disposition and the renal clearance of sulfamethazine and its N4-acetyl and hydroxy metabolites in calves and cows.
    Nouws JF; Vree TB; Baakman M; Driessens F; Breukink HJ; Mevius D
    Am J Vet Res; 1986 Mar; 47(3):642-9. PubMed ID: 3963566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible optimization of sulphadimidine dosage for acetylator phenotyping.
    Hombhanje F
    Jpn J Pharmacol; 1991 Aug; 56(4):531-4. PubMed ID: 1744992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetylation phenotype in colorectal carcinoma.
    Ilett KF; David BM; Detchon P; Castleden WM; Kwa R
    Cancer Res; 1987 Mar; 47(5):1466-9. PubMed ID: 3815349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.